At5g37473 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At5g37473 antibody; MPA22 antibody; T25O11 antibody; Putative defensin-like protein 277 antibody
Target Names
At5g37473
Uniprot No.

Target Background

Database Links

KEGG: ath:AT5G37473

STRING: 3702.AT5G37473.1

UniGene: At.63333

Protein Families
DEFL family
Subcellular Location
Secreted.

Q&A

What is AT5G37473 and why are antibodies against it important for research?

AT5G37473 appears to be an accession number referring to a specific gene in Arabidopsis thaliana, though it is not specifically mentioned in the provided gene lists . Antibodies targeting plant proteins like those encoded by AT5G genes are critical research tools that enable protein detection, localization studies, and functional characterization. These antibodies allow researchers to track protein expression patterns across different tissues, developmental stages, or in response to environmental stimuli. For plant molecular biology, antibodies against specific targets enable visualization of protein distribution using immunohistochemistry, quantification via immunoblotting, and characterization of protein interactions through immunoprecipitation techniques. When developing research involving AT5G37473 antibodies, researchers should first confirm the gene annotation is current, as plant genome annotations are periodically revised and updated in databases.

How do I validate an antibody against AT5G37473 for research applications?

Antibody validation is essential for ensuring experimental reliability and reproducibility. For AT5G37473 antibody validation, implement a multi-step process beginning with specificity assessment through Western blotting against wild-type plant extracts alongside knockout/knockdown mutants lacking the target protein. The FDA guidelines on immunoassay development emphasize that specificity testing should demonstrate minimal cross-reactivity with similar proteins . Additional validation methods should include immunoprecipitation followed by mass spectrometry to confirm target identity, and immunolocalization studies compared with fluorescent protein fusions to verify subcellular localization patterns. Researchers should document all validation steps, including antibody concentration optimization, buffer conditions tested, and positive/negative controls employed. The validation process should be particularly rigorous if the antibody will be used for quantitative applications rather than simple presence/absence detection. Always include comprehensive validation data in publications to enhance reproducibility across different laboratories.

What are the essential controls needed when using AT5G37473 antibodies in experimental procedures?

Proper experimental controls are critical for antibody-based research. For AT5G37473 antibody experiments, include the following controls: (1) Positive control: tissues/samples known to express the target protein; (2) Negative control: knockout/knockdown plant lines or tissues where the protein is not expressed; (3) Secondary antibody-only control to detect non-specific binding; (4) Pre-immune serum control (for polyclonal antibodies) or isotype control (for monoclonals); and (5) Peptide competition assay where pre-incubation of the antibody with the immunizing peptide should abolish specific signals . For experiments investigating protein-protein interactions, include controls addressing potential matrix effects and sample handling artifacts. The FDA guidance emphasizes that proper controls help identify potential interference from concomitant factors that might influence antibody binding . Document all controls systematically in laboratory notebooks and publication methods sections to ensure experimental rigor and facilitate troubleshooting of unexpected results.

How should I store and handle antibodies against plant proteins like AT5G37473 to maintain their functionality?

Proper storage and handling of antibodies is crucial for maintaining their specificity and sensitivity over time. Store antibodies against plant proteins according to manufacturer recommendations, typically at -20°C for long-term storage with addition of glycerol (50%) to prevent freeze-thaw damage. For working aliquots, store at 4°C with preservatives like sodium azide (0.02%) to prevent microbial contamination. Avoid repeated freeze-thaw cycles by preparing small working aliquots. Before each experimental use, centrifuge antibody solutions briefly to remove any aggregates. For plant tissue experiments, consider adding protease inhibitors and reducing agents to extraction buffers to preserve protein integrity during sample preparation. Document all storage conditions, handling procedures, and lot numbers in laboratory records to track potential variations in antibody performance over time. If decreased antibody performance is observed, perform validation tests again before concluding experimental results, as antibody degradation can lead to false negative results or increased background.

How can computational approaches improve antibody specificity for closely related plant proteins?

Computational modeling and biophysics-informed approaches can significantly enhance antibody specificity when targeting plant proteins with high sequence similarity to other family members. Recent advances demonstrate that computational models can disentangle different binding modes associated with specific ligands . For designing highly specific antibodies against AT5G37473, researchers can implement a multi-step computational process: (1) Identify potential epitopes unique to AT5G37473 through sequence alignment with related proteins; (2) Model structural features of the protein to identify surface-exposed regions; (3) Apply biophysics-informed models that can predict antibody-antigen interactions with customized specificity profiles . The energy functions associated with each binding mode can be optimized to either minimize interaction with undesired targets (for high specificity) or to promote cross-reactivity when desired . This approach has been validated experimentally through phage display experiments involving antibody selection against various combinations of ligands, confirming that computational approaches can successfully predict and design antibodies with desired specificity profiles . When implementing these methods, researchers should integrate experimental feedback to refine computational models iteratively.

What approaches can be used to design antibodies with customized specificity profiles for plant protein research?

Designing antibodies with customized specificity profiles for plant proteins requires sophisticated experimental and computational approaches. Research demonstrates that biophysics-informed models can generate antibody variants with predefined binding profiles that are either cross-specific (interacting with several distinct ligands) or highly specific (interacting with a single ligand while excluding others) . The practical implementation involves: (1) Conducting phage display experiments with antibody libraries against various combinations of target and similar proteins; (2) High-throughput sequencing of selected antibodies; (3) Constructing computational models that associate each potential ligand with a distinct binding mode; and (4) Optimizing energy functions to achieve desired specificity profiles . For example, to obtain specific antibodies against AT5G37473 while avoiding cross-reactivity with closely related proteins, researchers would minimize the energy function associated with AT5G37473 while maximizing those associated with potential cross-reactive proteins . The computational models can also predict outcomes for new combinations of ligands not present in the training data, enabling researchers to design novel antibody sequences with predefined binding profiles even before experimental validation .

How do post-translational modifications of AT5G37473 affect antibody recognition and experimental outcomes?

Post-translational modifications (PTMs) can dramatically affect antibody recognition of plant proteins, leading to potential misinterpretation of experimental results. For AT5G37473 research, consider that plant proteins commonly undergo modifications including phosphorylation, glycosylation, ubiquitination, and SUMOylation, which may either mask or create epitopes. When designing experiments, researchers should determine if their antibody recognizes the modified or unmodified form of the protein through techniques like phosphatase treatment (for phosphorylation) or deglycosylation assays (for glycosylation) prior to immunoblotting. If differential recognition is observed, this information must be incorporated into experimental design and data interpretation. If the antibody fails to recognize certain modified forms, complementary approaches such as PTM-specific antibodies or mass spectrometry should be employed. Researchers should create a comprehensive experimental matrix documenting how different treatments affecting PTMs influence antibody recognition patterns. This information is critical for accurate interpretation of protein abundance, localization, or interaction studies, especially when comparing across different physiological or stress conditions that might alter the PTM landscape.

What are the most effective strategies for multiplexed detection of plant proteins including AT5G37473?

Multiplexed detection of plant proteins requires careful optimization to achieve simultaneous visualization of multiple targets while maintaining specificity. For including AT5G37473 in multiplexed assays, consider these advanced strategies: (1) Spectral unmixing immunofluorescence using antibodies from different host species labeled with spectrally distinct fluorophores; (2) Sequential immunostaining with complete elution of antibodies between rounds; (3) Mass cytometry (CyTOF) using metal-conjugated antibodies for highly multiplexed detection without spectral overlap concerns; or (4) Microfluidic immunoassays with spatial separation of detection regions. When designing multiplexed protocols, test each antibody individually before combining to establish baseline performance metrics and optimize antibody concentrations to balance signal intensity across targets. Create a detailed validation matrix documenting potential cross-reactivity between each primary-secondary antibody pair in the multiplex panel. Control experiments should include single-stained samples and fluorescence minus one (FMO) controls to accurately set detection thresholds. For quantitative applications, incorporate internal calibration standards to normalize signal intensities across experimental runs, allowing for more reliable comparisons between samples and experimental conditions.

What are the key differences between polyclonal and monoclonal antibodies for AT5G37473 detection?

CharacteristicPolyclonal AntibodiesMonoclonal Antibodies
Target recognitionMultiple epitopesSingle epitope
Signal strengthGenerally strongerMay require signal amplification
Batch consistencyVariable between productionsHighly consistent
Epitope accessibilityLess affected by protein conformationMore sensitive to conformational changes
Cross-reactivityHigher potentialTypically more specific
Suitability for detectionExcellent for low-abundance proteinsBetter for distinguishing closely related proteins
Production complexitySimpler, fasterMore complex, time-consuming
CostGenerally lowerGenerally higher
When choosing between these antibody types for AT5G37473 research, consider your experimental objectives: use polyclonals for initial detection and localization studies, particularly with low-abundance proteins, and monoclonals for distinguishing between closely related family members or for standardized assays requiring high reproducibility across multiple studies .

How should I optimize protein extraction protocols for antibody-based detection of AT5G37473 in plant tissues?

Optimizing protein extraction for antibody-based detection of plant proteins requires addressing the unique challenges of plant tissues. Develop a tailored extraction protocol considering: (1) Tissue-specific composition - seeds, leaves, and roots contain different interfering compounds requiring distinct extraction approaches; (2) Cell wall disruption - thorough mechanical homogenization in liquid nitrogen is essential; (3) Interfering compounds - remove phenolics, terpenes, and secondary metabolites using polyvinylpolypyrrolidone (PVPP), β-mercaptoethanol, or specialized buffers; and (4) Subcellular localization - modify extraction conditions based on the protein's localization (membrane, nuclear, chloroplastic, etc.). For AT5G37473, first attempt extraction with a standard protocol like TRIzol or phenol-based extraction, then optimize based on initial results. Compare multiple extraction methods side-by-side:

Extraction MethodAdvantagesDisadvantagesBest For
RIPA bufferGood for membrane and cytosolic proteinsMay not extract nuclear proteins efficientlyGeneral screening
Phenol extractionRemoves interfering compoundsMore labor-intensiveTissues with high phenolic content
TCA/acetoneConcentrates proteins effectivelyMay affect epitope recognitionLow-abundance proteins
Native extractionPreserves protein complexesLess efficient extractionProtein interaction studies
Document extraction efficiency through total protein quantification and detection of your target protein across different methods. Include extraction controls (e.g., detection of consistent reference proteins) to normalize results across different samples and extraction methods .

What immunoprecipitation approaches are most effective for studying protein interactions involving AT5G37473?

For studying protein interactions involving plant proteins like AT5G37473, several immunoprecipitation (IP) approaches can be implemented with varying strengths for different research questions. Standard IP using antibody-coupled beads works well for stable, high-affinity interactions but may miss transient or weak interactions. For these challenging interactions, consider crosslinking approaches using formaldehyde or specialized crosslinkers prior to cell lysis. Proximity-dependent biotinylation (BioID or TurboID) can capture both stable and transient interactions through biotinylation of proximal proteins in living cells, followed by streptavidin pulldown. When designing IP experiments, optimize lysis conditions based on subcellular localization - use gentler detergents (0.5% NP-40 or 1% digitonin) for maintaining complex integrity versus stronger disruption (1% SDS with dilution before IP) for accessing nuclear or membrane-bound proteins. Controls should include: (1) IP with non-specific IgG; (2) IP from tissues lacking the target protein; and (3) Reciprocal IP where available. For stringent validation of interactions, implement a dual-tagging strategy where both interacting proteins are tagged differently and sequential IP confirms specific interaction. Following IP, analyze samples using either targeted approaches (immunoblotting) or unbiased methods (mass spectrometry) depending on whether you're confirming suspected interactions or discovering new ones.

How can I quantitatively assess antibody specificity and sensitivity for AT5G37473 detection?

Quantitative assessment of antibody specificity and sensitivity is essential for robust research outcomes. Implement a systematic approach including: (1) Dose-response testing using purified recombinant AT5G37473 protein at concentrations ranging from picogram to microgram levels to determine detection limits; (2) Competition assays where increasing amounts of purified antigen are added to samples before antibody incubation, with true specific binding showing proportional signal reduction; and (3) Cross-reactivity testing against related proteins, particularly those with high sequence homology. Quantify specificity using a specificity index (SI) calculated as: SI = (Signal from target protein)/(Signal from highest cross-reactive protein). For plant proteins like AT5G37473, also test specificity across different plant species if planning cross-species applications. Sensitivity should be quantified through limit of detection (LOD) and limit of quantification (LOQ) determinations following FDA guidelines for immunoassays . LOD is typically defined as 3 standard deviations above background signal, while LOQ requires 10 standard deviations above background. Create standard curves using purified protein to establish the linear detection range and determine if sample dilution strategies are needed for quantitative applications. Document all validation parameters systematically, including the specific methodology used to determine each metric, as this information is critical for comparison across different antibodies and experimental conditions.

What are common causes of non-specific binding when using antibodies against plant proteins, and how can they be mitigated?

Non-specific binding is a common challenge when working with plant samples due to their complex biochemical composition. Common causes include: (1) Insufficient blocking - plant tissues contain diverse proteins and metabolites that can interact with antibodies; (2) Cross-reactive epitopes in related proteins; (3) Protein denaturation exposing normally hidden epitopes; (4) Plant-specific compounds interfering with antibody binding; and (5) Secondary antibody cross-reactivity. To mitigate these issues, implement a systematic optimization strategy:

IssueOptimization ApproachImplementation Details
Insufficient blockingTest multiple blocking agentsCompare BSA, casein, non-fat milk, normal serum from secondary antibody host, and plant-specific blockers like plant protein extracts from knockout lines
High backgroundModify washing conditionsIncrease washing duration, number of washes, and detergent concentration (0.1-0.5% Tween-20 or Triton X-100)
Cross-reactivityAntibody pre-adsorptionPre-incubate antibody with extracts from tissues lacking the target protein
Secondary antibody issuesTest different secondary antibodiesCompare various suppliers and conjugates, and use highly cross-adsorbed secondaries
Buffer interferenceOptimize buffer compositionTest different buffer systems (PBS, TBS, HEPES) with varying salt concentrations (150-500 mM)
Document each optimization systematically and maintain detailed protocols of successful conditions for future reference. For particularly challenging applications, consider developing a specialized immunoassay with customized buffer systems and blocking strategies tailored to the specific plant tissue and target protein .

How can I troubleshoot weak or absent signals when using AT5G37473 antibodies?

When encountering weak or absent signals with plant protein antibodies, implement a systematic troubleshooting approach addressing multiple potential causes. First, evaluate antibody functionality using positive controls like recombinant protein or overexpression systems. If controls work but experimental samples fail, consider protein abundance issues - the target may be expressed at levels below detection limits, requiring enrichment through immunoprecipitation or subcellular fractionation before detection. Next, assess epitope accessibility problems, which are common in plant samples due to complex matrices. Try multiple protein denaturation approaches (heat, reducing agents, detergents) and extraction methods. For fixed samples, test different antigen retrieval methods including citrate buffer heating, enzymatic digestion, or pressure cooking. Additionally, signal amplification techniques can overcome detection challenges - implement tyramide signal amplification, polymer-based detection systems, or biotin-streptavidin amplification to enhance sensitivity 10-100 fold. Finally, optimize incubation conditions by testing different antibody concentrations (using a matrix of primary and secondary antibody dilutions), extending incubation times (4°C overnight vs. room temperature for 1-2 hours), and modifying buffer composition. Document all troubleshooting steps systematically, comparing signal-to-noise ratios quantitatively across different conditions to identify optimal detection parameters.

What strategies can reduce background noise in immunolocalization studies of plant tissues?

Immunolocalization in plant tissues presents unique challenges due to autofluorescence, cell wall barriers, and vacuolar compartmentalization. To reduce background noise, implement a comprehensive optimization strategy addressing multiple factors: (1) Fixation protocol - compare cross-linking fixatives (paraformaldehyde, glutaraldehyde) versus precipitating fixatives (methanol, acetone) to determine which best preserves antigenicity while maintaining tissue architecture; (2) Autofluorescence reduction - pretreat sections with sodium borohydride (0.1% for 10 minutes) to reduce aldehyde-induced fluorescence, or use Sudan Black B (0.1-1% in 70% ethanol) to quench lipofuscin autofluorescence; (3) Permeabilization optimization - test graduated ethanol series, detergents (Triton X-100, Tween-20), or enzymatic digestion (pectolyase, cellulase) to improve antibody penetration without destroying tissue structure; and (4) Detection system selection - compare direct fluorophore conjugation versus multi-step detection systems based on signal-to-noise ratio. For particularly challenging plant tissues, implement advanced techniques including: optical clearing methods (ClearSee, PEA-CLARITY) to improve signal detection depth; spectral unmixing to separate antibody signal from autofluorescence; confocal microscopy with narrow bandpass filters; and signal deconvolution algorithms during image processing. Document all optimization steps with quantitative image analysis measuring signal-to-background ratios to identify conditions that maximize specific signal while minimizing background interference.

How do I determine the optimal antibody concentration for different experimental applications?

Determining optimal antibody concentration requires systematic titration across different experimental applications. For immunoblotting, perform a gradient titration using a constant amount of positive control protein with primary antibody dilutions ranging from 1:100 to 1:10,000, then select the concentration providing the best signal-to-noise ratio rather than the strongest absolute signal. For immunohistochemistry and immunofluorescence, create a titration matrix combining different antibody concentrations (typically 1-10 μg/ml) with various incubation times and temperatures. When optimizing for flow cytometry, compare antibody concentration against median fluorescence intensity to identify saturation points (where increasing antibody no longer improves detection) and background staining thresholds. For immunoprecipitation, determine the minimum antibody concentration that efficiently depletes the target protein from the supernatant while minimizing non-specific binding. Document optimization through quantitative metrics:

ApplicationPrimary MetricSecondary ConsiderationsTypical Optimal Range
Western blotSignal-to-background ratioBand specificity, linear dynamic range0.1-1 μg/ml
ImmunofluorescenceSpecific signal intensity vs. backgroundPenetration depth, morphology preservation1-10 μg/ml
ELISAStandard curve linearityDetection limits, reproducibility0.5-5 μg/ml
Flow cytometrySeparation index between positive and negative populationsMinimal spillover, consistency across samples0.25-2 μg/ml
ImmunoprecipitationTarget depletion efficiencyNon-specific binding2-10 μg per reaction
Create detailed records of optimization experiments to avoid repeated titrations and ensure consistent results across multiple studies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.